Kera Capital Partners, Inc. Eli Lilly & CO Transaction History
Kera Capital Partners, Inc.
- $336 Billion
- Q1 2025
A detailed history of Kera Capital Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 300 shares of LLY stock, worth $247,773. This represents 0.07% of its overall portfolio holdings.
Number of Shares
300
Previous 299
0.33%
Holding current value
$247,773
Previous $231 Million
7.34%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,295Shares Held
745MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$80 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$61.3 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$54.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$42.4 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$28.3 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $785B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...